Shlomit Jessel

Publication Activity (10 Years)

Years Active: 2021-2021
Publications (10 Years): 2

Top Topics

Basal Cell Carcinoma

High Throughput

Top Venues

Science (New York, N.Y.)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah A Weiss, Dijana Djureinovic, Shlomit Jessel, Irina Krykbaeva, Lin Zhang, Lucia Jilaveanu, Amanda Ralabate, Barbara Johnson, Neta Shanwetter Levit, Gail Anderson, Daniel Zelterman, Wei Wei, Amit Mahajan, Ovid Trifan, Marcus Bosenberg, Susan M Kaech, Curtis J Perry, William E Damsky, Scott Gettinger, Mario Sznol, Michael Hurwitz, Harriet M Kluger
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non-Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Sneha Berry, Nicolas A Giraldo, Benjamin F Green, Tricia R Cottrell, Julie E Stein, Elizabeth L Engle, Haiying Xu, Aleksandra Ogurtsova, Charles Roberts, Daphne Wang, Peter Nguyen, Qingfeng Zhu, Sigfredo Soto-Diaz, Jose Loyola, Inbal B Sander, Pok Fai Wong, Shlomit Jessel, Joshua Doyle, Danielle Signer, Richard Wilton, Jeffrey S Roskes, Margaret Eminizer, Seyoun Park, Joel C Sunshine, Elizabeth D Thompson, Alexander S Baras, Angelo M DeMarzo, Suzanne L Topalian, Harriet Kluger, Leslie Cope, Evan J Lipson, Ludmila V Danilova, Robert A Anders, David L Rimm, Drew M Pardoll, Alexander S Szalay, Janis M Taube
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade. Science (New York, N.Y.) 372 (6547) (2021)